Article Information
History
- March 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Suzanne Pickering1,
- Rahul Batra2,
- Luke B. Snell2,
- Blair Merrick2,
- Gaia Nebbia2,
- Sam Douthwaite2,
- Amita Patel2,
- Mark Tan Kia Ik2,
- Bindi Patel2,
- Themoula Charalampous2,
- Adela Alcolea-Medina2,3,
- Maria Jose Lista1,
- Penelope R. Cliff3,
- Emma Cunningham3,
- Jane Mullen3,
- Katie J. Doores1,
- Jonathan D. Edgeworth1,2,
- Michael H. Malim1,
- Stuart J.D. Neil1,* and
- Rui Pedro Galão1,*
- 1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London SE1 9RT, UK
- 2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London SE1 7EH
- 3Viapath Group LLP, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- ↵*Joint corresponding authors: Rui Pedro Galão rui_pedro.galao{at}kcl.ac.uk, +44 207 848 2610, Stuart J.D. Neil stuart.neil{at}kcl.ac.uk, +44 207 848 9617
Posted March 02, 2021.
Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens
